FDA: Budesonide in vitro PBE [Power / Sample Size]

posted by mittyri  – Russia, 2016-07-07 16:17 (3175 d 00:51 ago) – Posting: # 16478
Views: 7,743

Hi Helmut,

If I understood correctly, simulation is the best choice, something like this:
Morgan B, Strickland H. Performance Properties of the Population Bioequivalence Approach for In Vitro Delivered Dose for Orally Inhaled Respiratory Products. The AAPS Journal. 2014;16(1):89-100. doi:10.1208/s12248-013-9543-x.

Is that an enhancement request to "Swiss army knife for lazy guys dealing with BE studies"?:-D

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,409 posts in 4,921 threads, 1,666 registered users;
24 visitors (0 registered, 24 guests [including 10 identified bots]).
Forum time: 16:08 CET (Europe/Vienna)

There are only two kinds of scholars;
those who love ideas and those who hate them.    Emile Chartier

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5